Atlas Trials

Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem

Clinical trial NCT05106127 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05106127
Sponsor
Evergreen Therapeutics, Inc.
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Endometrial Cancer
Start date
2026-08-01
Primary completion
2027-03-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.